FLU A+B Nasal Swab Clinical Study
FLU A+B Nasal Swab Clinical Study
The purpose of this clinical study is to obtain clearance for the nasal swab sample type by
 demonstrating the performance characteristics of the FLU A+B Test versus standard laboratory
 culture for Influenza A and B viruses using nasal swab samples.
Patients exhibiting symptoms of influenza enrolled in a fashion that confidentiality of all
 personal health information is maintained.

 No patient treatment is affected by enrollment in this trial.
Inclusion Criteria:

 -  Male and Female of all age groups

 -  Patients exhibiting influenza symptoms (i.e., fever, body aches, headaches, cough,
 sore throat, and other respiratory symptoms) at the time of examination

 -  Patients must either present with a fever (>100ºF; >37.8ºC) at time of examination or
 have had a fever (>100ºF; >37.8ºC) or declare at time of the examination that they had
 a fever within the previous 3 days prior to the examination

 -  Must be able to collect sample using the nasal swab sample type

 Exclusion Criteria:

 -  Patients with no fever at time of examination or within the 3 days prior to
 examination and/or are currently undergoing treatment (including anti-virals) will be
 excluded from the study.